๐ฐ Fran Gregory News
Page 2 - Fran Gregory News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fran Gregory. Real-time updates on events, politics, business and more.
December 19, 2023
Fran Gregory, PharmD, MBA, vice president of emerging therapies at Cardinal Health, discusses the dynamic landscape of the biosimilars market, providing key insights into its current status and future projections.
August 28, 2023
Perhaps the most significant development in the pharmaceutical industry in decades, crops of biosimilars are being approved and are ready for distribution. What lies next, in terms of legislation and the impact on pharmacists, remains to be seen.
July 28, 2023
A panel of experts discuss the state of biosimilars today and the importance of standardizing knowledge of the field.
May 15, 2023
Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the role biosimilars are playing in the pharmaceutical market as well as in patient access.
May 9, 2023
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses the role the new wave of biosimilars will have on rebate practices for both pharmacy benefit managers (PBMs) and payers.
May 4, 2023
Gregory also discussed the differences between specialty pharmacy distribution and physicianโs office distribution, and the benefits of each for patients.
May 2, 2023
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses what's to come as a result of a "second wave" of biosimilars hitting the market.
May 2, 2023
Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption.
March 7, 2023
Through the partnership, Signify Health clinicians will be able to use Cardinal's OutcomesOne platform and perform an in-home, CMS-compliant medication review to determine which members are not taking their medications as prescribed and address those needs.